AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, today announced an agreement with Brigham and Women's Hospital for an investigator-initiated study led by Richard D. Urman MD, MBA, Associate Professor of Anesthesia and co-director of the Center for Perioperative Research at Brigham and Women's Hospital and Harvard Medical School. Read More »

The American Pharmacists Association (APhA) recommends that patients and/or caregivers ensure that they have adequate supplies of necessary medications to address their needs if not able to get to the pharmacy because of coronavirus. Read More »

Leading health tech company is the first to introduce novel approach to addressing the COVID-19 pandemic Read More »

UCSF Health, Northwell Health, UNC Health and other systems using Conversa's virtual care and communication platform to triage people in their communities, manage patients, and screen healthcare workers Read More »

The Synthetic Biology Leader Steps Out to Help Fight COVID-19 Read More »